Treatment of malignant pheochromocytomas with 131-I metaiodobenzylguanidine and chemotherapy

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 22, Issue 4, 1999, Pages 364-370

  Sisson, James C ^a,b   Shapiro, Brahm ^a   Shulkin, Barry L ^a   Urba, Susan ^a   Zempel, Shirley ^a   Spaulding, Susan ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

131 I MIBG; Chemotherapy; Malignant pheochromocytomas

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 131; CISPLATIN; DACARBAZINE; VINCRISTINE;

ARTICLE; CANCER REGRESSION; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DOSIMETRY; DRUG EXCRETION; EXCRETION; HUMAN; PHEOCHROMOCYTOMA; RADIATION DOSE; RADIOACTIVITY; TUMOR VOLUME;

3-IODOBENZYLGUANIDINE; ADRENAL GLAND NEOPLASMS; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; DACARBAZINE; FEMALE; HUMANS; MALE; MIDDLE AGED; PHEOCHROMOCYTOMA; RADIOPHARMACEUTICALS; VINCRISTINE;

EID: 0033501955     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000421-199908000-00008     Document Type: Article

References (25)

1. Sisson JC, Shapiro B, Beierwaltes WH, et al. Radiopharmaceutical treatment of malignant pheochromocytoma. J Nucl Med 1984;25: 197-206.
2. Averbuch SD, Steakley CS, Young RC, et al. Malignant pheochromocytoma: effective treatment with a combination of cyclophosphamide, vincristine, and dacarbazine. Ann Intern Med 1988;109: 267-73.
3. 131I]iodobenzylguanidine in the treatment of malignant pheochromocytoma. J Clin Endocrinol Metab 1991;72:455-61.
4. 131I]metaiodobenzylguanidine: results from ten years of experience. J Nucl Biol Med 1992;35:269-76.
5. Lewington VJ, Zivanovic MA, Tristam M, et al. Radiolabelled metaiodobenzylguanidine targeted radiotherapy for malignant phaeochromocytoma. J Nucl Biol Med 1992;35:280-3.
6. 131I]metaiodobenzylguanidine treatment in metastatic malignant phaeochromocytoma. J Nucl Biol Med 1992;35:277-9.
7. 131I]Metaiodobenzylguanidine therapy in 20 patients with malignant pheochromocytoma. J Nucl Biol Med 1992;35:288-91.
8. 131I]metaiodobenzyl-guanidine. J Nucl Biol Med 1992;35:292-4.
9. 131I]Metaiodobenzylguanidine treatment of malignant pheochromo-cytoma: experience of the Rome Group. J Nucl Biol Med 1992;35:295-9.
10. 131I]metaiodobenzylguanidine treatment in metastatic malignant pheochromocytoma. J Nucl Biol Med 1992;35:300-4.
11. 131I]metaiodobenzylguanidine therapy administered to three patients with malignant pheochromocytoma. J Nucl Biol Med 1992;35:305-7.
12. 131I]Metaiodobenzylguanidine treatment of a malignant paraganglioma. J Nucl Biol Med 1992;35:313-4.
13. 131I-metaiodobenzylguanidine therapy for malignant pheochromocytoma. Ann Nucl Med 1994;8: 133-7.
14. Ball ABS, Tait DM, Fisher C, et al. Treatment of metastatic para-aortic paraganglioma by surgery, radiotherapy and I-131 MIBG. Eur J Surg Oncol 1991;17:543-6.
15. Schlumberger M, Gicquel C, Lumbroso J, et al. Malignant pheochromocytoma: clinical, biological, histologic and therapeutic data in a series of 20 patients with distant metastases. J Endocrinol Invest 1992;15:631-42.
16. Mornex R, Badet C, Peyrin L. Malignant pheochromocytoma: a series of 14 cases observed between 1966 and 1990. J Endocrinol Invest 1992;15:643-9.
17. Bomanji J, Britton KE, Ur E, et al. Treatment of malignant phaeochromocytoma, paraganglioma and carcinoid tumours with 131-I-metaiodobenzylguanidine. Nucl Med Commun 1993;14: 856-61.
18. Noshiro T, Honma H, Shimizu K, et al. Two cases of malignant pheochromocytoma treated with cyclophosphamide, vincristine and dacarbazine in a combined chemotherapy. Endocr J 1996;43: 279-84.
19. Karnofsky DA, Abelman WH, Craver LF, et al. The use of the nitrogen mustards in the palliative treatment of carcinoma. Cancer 1948;1:634-56.
20. 131I-meta-iodobenzylguanidine. Eur J Nucl Med 1988;14:337-40.
21. Sisson JC, Jamadar DA, Kazerooni EA, et al. Treatment of micronodular lung metastases from papillary thyroid cancer: are the tumors too small for effective radiation from 131-I? Thyroid 1998;8:215-21.
22. Kline RC, Swanson DP, Wieland DM, et al. Myocardial imaging in man with 123-I meta-iodobenzylguanidine. J Nucl Med 1981; 22:129-32.
23. Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer 1981;47:207-14.
24. Mangner TJ, Wu JL, Wieland DM. Solid phase exchange radioiodination of aryl iodides. Facilitation by amonium sulfate. J Org Chem 1982;47:1484-8.
25. Bongers V, de Klerk JMH, Zonnenberg BA, et al. Acute liver necrosis induced by iodine-131-MIBG in the treatment of metastatic carcinoid tumors. J Nucl Med 1997;38:1024-6.